Body Composition, Cardiometabolic Risk Factors and Comorbidities in Psoriasis and the Effect of HLA-C*06:02 Status: The HUNT Study, Norway
Keywords:Comorbidity, Epidemiology, Genetics, Psoriasis
Abstract is missing (Short communication)
Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ 2020; 369: m1590.
https://doi.org/10.1136/bmj.m1590 DOI: https://doi.org/10.1136/bmj.m1590
Modalsli EH, Snekvik I, Asvold BO, Romundstad PR, Naldi L, Saunes M. Validity of self-reported psoriasis in a general population: the HUNT Study, Norway. J Invest Dermatol 2016; 136: 323-325.
https://doi.org/10.1038/JID.2015.386 DOI: https://doi.org/10.1038/JID.2015.386
Danielsen K, Olsen AO, Wilsgaard T, Furberg AS. Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort. Br J Dermatol 2013; 168: 1303-1310.
https://doi.org/10.1111/bjd.12230 DOI: https://doi.org/10.1111/bjd.12230
Elmets CA, Leonardi CL, Davis DMR, Gelfand JM, Lichten J, Mehta NN, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol 2019; 80: 1073-1113.
https://doi.org/10.1016/j.jaad.2018.11.058 DOI: https://doi.org/10.1016/j.jaad.2018.11.058
Blake T, Gullick NJ, Hutchinson CE, Barber TM. Psoriatic disease and body composition: a systematic review and narrative synthesis. PloS One 2020; 15: e0237598-e0237598.
https://doi.org/10.1371/journal.pone.0237598 DOI: https://doi.org/10.1371/journal.pone.0237598
Douroudis K, Ramessur R, Barbosa IA, Baudry D, Duckworth M, Angit C, et al. Differences in clinical features and comorbid burden between HLA-C*06:02 carrier groups in >9,000 people with psoriasis. J Invest Dermatol 2022; 142: 1617-1628.e1610.
https://doi.org/10.26226/morressier.61081ff8bc981037240fe3af DOI: https://doi.org/10.26226/morressier.61081ff8bc981037240fe3af
Dand N, Duckworth M, Baudry D, Russell A, Curtis CJ, Lee SH, et al. HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis. J Allergy Clin Immunol 2019; 143: 2120-2130.
https://doi.org/10.1016/j.jaci.2018.11.038 DOI: https://doi.org/10.1016/j.jaci.2018.11.038
Svedbom A, Mallbris L, Larsson P, Nikamo P, Wolk K, Kjellman P, et al. Long-term outcomes and prognosis in new-onset psoriasis. JAMA Dermatol 2021; 157: 684-690.
https://doi.org/10.1001/jamadermatol.2021.0734 DOI: https://doi.org/10.1001/jamadermatol.2021.0734
Åsvold BO, Langhammer A, Rehn TA, Kjelvik G, Grøntvedt TV, Sørgjerd EP, et al. Cohort profile update: the HUNT study, Norway. Int J Epidemiol 2023; 52: e80-e91.
https://doi.org/10.1093/ije/dyac095 DOI: https://doi.org/10.1093/ije/dyac095
Brumpton BM, Graham S, Surakka I, Skogholt AH, Løset M, Fritsche LG, et al. The HUNT study: a population- based cohort for genetic research. Cell Genomics 2022; 2: 100193.
https://doi.org/10.1016/j.xgen.2022.100193 DOI: https://doi.org/10.1016/j.xgen.2022.100193
Hao Y, Zhu Y-j, Zou S, Zhou P, Hu Y-w, Zhao Q-x, et al. Metabolic syndrome and psoriasis: mechanisms and future directions. Front Immunol 2021; 12: 711060.
https://doi.org/10.3389/fimmu.2021.711060 DOI: https://doi.org/10.3389/fimmu.2021.711060
Enos CW, Ramos VL, McLean RR, Lin T-C, Foster N, Dube B, et al. Comorbid obesity and history of diabetes are independently associated with poorer treatment response to biologics at 6 months: a prospective analysis in Corrona Psoriasis Registry. J Am Acad Dermatol 2022; 86: 68-76.
https://doi.org/10.1016/j.jaad.2021.06.883 DOI: https://doi.org/10.1016/j.jaad.2021.06.883
How to Cite
Copyright (c) 2023 Åshild Øksnevad Solvin, Vera V. Bjarkø, Laurent F. Thomas, Patricia Berrospi, Kristian Hveem, Marit Saunes, Bjørn O. Åsvold, Mari Løset
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.